When is sentinel node biopsy for breast cancer contraindicated? (Q35212723)

7 August 2017

1 reference

title

When is sentinel node biopsy for breast cancer contraindicated? (English)

1 reference

7 August 2017

1 reference

Helen Krontiras

1

1 reference

PubMed ID

12957625

7 August 2017

Kirby I Bland

series ordinal

2

1 reference

7 August 2017

1 November 2003

1 reference

7 August 2017

1 reference

7 August 2017

12

1 reference

7 August 2017

3

1 reference

7 August 2017

207-210

1 reference

Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Improved axillary staging of breast cancer with sentinel lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Breast cancer Clinical Practice Guidelines in Oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Analysis of sentinel lymph node mapping with immediate pathologic review in patients receiving preoperative chemotherapy for breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Subareolar versus peritumoral injection for location of the sentinel lymph node

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel node biopsy in ductal carcinoma in situ patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Principles and controversies in lymphoscintigraphy with emphasis on breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

The sentinel node in breast cancer--a multicenter validation study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Intraoperative examination of the sentinel lymph node for breast carcinoma staging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2802%2900051-8

7 January 2021

10.1016/S0960-7404(02)00051-8

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12957625